Advertisement

Lasers for Aesthetic and Functional Vaginal Rejuvenation

  • André Vinícius de Assis Florentino
  • Thales Lage Bicalho Bretas
  • Maria Claudia Almeida Issa
Living reference work entry
Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)

Abstract

Vaginal rejuvenation has been popped up recently due to the increase in life expectancy and the search for a better quality of life. Nowadays, women live one-third of their lives after menopause, demanding efforts to keep their sexual life up to their body and mind’s health. Advances in laser therapy have made this possible, reversing vulvovaginal atrophy and its symptoms, known as genitourinary syndrome of menopause, including vaginal dryness, dyspareunia, decrease in sexual arousal and orgasm, stress urinary incontinence, and vaginal bleeding. Carbon dioxide laser (CO2) and the erbium laser (Er:YAG) are the most common lasers used for female rejuvenation. They promote neocollagenesis and neovascularization in the connective tissue of the vaginal wall, as well as recover the mucosal epithelium, restoring lubrication and elasticity of vaginal walls.

Keywords

CO2 laser Erbium laser Er:YAG Genitourinary syndrome of menopause Intimate laser Menopause Radiofrequency Urinary incontinence Vaginal laxity Vaginal rejuvenation Vulvovaginal atrophy 

References

  1. Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58:719–37.CrossRefPubMedGoogle Scholar
  2. Anderson DJ, Marathe J, Pudney J. The structure of the human vaginal stratum corneum and its role in immune defense. Am J Reprod Immunol. 2014;71:618–23.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Athanasiou S, Pitsouni E, Antonopoulou S, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016;19(5):512–8. doi:10.1080/13697137.2016.1212006.CrossRefPubMedGoogle Scholar
  4. Bachmann GA, Notelovitz M, Kelly SJ, et al. Long-term nonhormonal treatment of vaginal dryness. Clin Pract Sex. 1992;8:3–8.Google Scholar
  5. Beeson WH, Rachel JD. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing. Dermatol Surg. 2002;28(4):331–6.PubMedGoogle Scholar
  6. Bygdeman M, Swahn M. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas. 1996;23:259–63.CrossRefPubMedGoogle Scholar
  7. Fisher JC. Photons, physiatrics, and physicians. A practical guide to understanding laser light interaction with living tissue, part 1. J Clin Laser Med Surg. 1992;10(6):419–26.PubMedGoogle Scholar
  8. Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol. 2015;67(2):97–102.PubMedGoogle Scholar
  9. Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18:757–63.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg. 2011;28:156–62.CrossRefGoogle Scholar
  11. Gaviria JE, Lanz JA. Laser vaginal tightening (LVT) – evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J Laser Health Acad. 2012;2012(1):59–66.Google Scholar
  12. Kaplan I, Goldman J, Ger R. The treatment of erosions of the uterino cervix by means of the CO2 laser. Obstet Gynecol. 1973;41(5):795–6.PubMedGoogle Scholar
  13. Mehta A, Bachmann G. Vulvovaginal complaints. Clin Obstet Gynecol. 2008;51(3):549–55.CrossRefPubMedGoogle Scholar
  14. Murina F, Karram M, Salvatore S, Felice R. Fractional CO2 laser treatment of the vestibule for patients with vestibulodynia and genitourinary syndrome of menopause: a pilot study. J Sex Med. 2016;13:1915.CrossRefPubMedGoogle Scholar
  15. NAMS. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause. 2013;20(9):888–902.CrossRefGoogle Scholar
  16. Perino A, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post menopausal women? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20(12):2491–7.PubMedGoogle Scholar
  17. Portman DJ, Gass ML, Vulvovaginal Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Climacteric. 2014;17:557–63.CrossRefPubMedGoogle Scholar
  18. Prignano F, Campolmi P, Bonan P, et al. Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodelling and cytokine pathway of tissue repair. Dermatol Ther. 2009;22(Suppl 1):S8–S15.CrossRefPubMedGoogle Scholar
  19. Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional Co2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17:363–9.CrossRefPubMedGoogle Scholar
  20. Salvatore S, Maggiore ULR, Athanasiou S, Origoni M, Candiani M, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22(8):845–9.CrossRefPubMedGoogle Scholar
  21. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6:2133–42.CrossRefPubMedGoogle Scholar
  22. Sasaki GH, Travis HM, Tucker B. Fractional CO2 laser resurfacing of photoaged facial and non-facial skin: histologic and clinical results and side effects. J Cosmet Laser Ther. 2009;11:190–201.CrossRefPubMedGoogle Scholar
  23. Sokol ER, Karram MM. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause. 2016;23:1102–7.CrossRefPubMedGoogle Scholar
  24. Sturdee DW, Panay N, International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–22.CrossRefPubMedGoogle Scholar
  25. Vanaman M, Bolton J, Placik O, Fabi SG. Emerging trends in nonsurgical female genital rejuvenation. Dermatol Surg. 2016;42(9):1019–29.CrossRefPubMedGoogle Scholar
  26. Vizintin Z, Rivera M, Fistonić I, Saraçoğlu F, Guimares P, et al. Novel minimally invasive VSP Er:YAG laser treatments in gynecology. J Laser Health Acad. 2012;2012(1):46–58.Google Scholar
  27. Vizintin Z, Lukac M, Kazic M, Tettamanti M. Erbium laser in gynecology. Climacteric. 2015;18(Suppl 1):4–8.CrossRefPubMedGoogle Scholar
  28. Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30:429–36.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • André Vinícius de Assis Florentino
    • 1
    • 2
  • Thales Lage Bicalho Bretas
    • 3
  • Maria Claudia Almeida Issa
    • 3
  1. 1.Department of GynecologyFaculdade de Ciências Médicas de Campina GrandeCampina GrandeBrazil
  2. 2.Brazilian Federation of Gynecology and ObstetricsSão PauloBrazil
  3. 3.Universidade Federal FluminenseNiteróiBrazil

Personalised recommendations